IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 277 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $287,000 | -41.3% | 7,175 | -29.8% | 0.16% | -43.8% |
Q4 2016 | $489,000 | +17.3% | 10,225 | -10.1% | 0.28% | +17.9% |
Q3 2016 | $417,000 | +29.9% | 11,370 | -17.4% | 0.24% | +13.2% |
Q2 2016 | $321,000 | -42.4% | 13,770 | 0.0% | 0.21% | -42.7% |
Q1 2016 | $557,000 | -33.6% | 13,770 | +1.8% | 0.37% | -36.9% |
Q4 2015 | $839,000 | – | 13,520 | – | 0.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |